N-PORT filing recap · June 2026
What did Hillman Value Fund buy in June 2026?
Reported stock-position changes between this filing and the previous one. These are Hillman Value Fund's own holdings, not the firm's.
Stock value
$75.56M
Positions
37
Estimated turnover
18.8%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
Hillman Value Fund opened new positions in Veeva Systems and Dupont De Nemours, while exiting Dupont De Nemours and Price T Rowe Group. The fund trimmed a broad swath of holdings, including West Pharmaceutical Services, CVS Health, Taiwan Semiconductor Manufacturing, UnitedHealth Group, Biogen, Bristol-Myers Squibb, International Flavors & Fragrances, US Bancorp, Carmax, Verizon Communications, Pfizer, Constellation Brands, Akamai Technologies, and Oracle. It added to Conagra Brands, Salesforce, and Adobe.